CLINICAL_TRIALS
trial_result
· 2018-01-25
Clinical Trial Update: A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD [Phase 2]
Summary
Phase 2 dose-range finding study of SUN-101 in adults with moderate to severe COPD was completed and results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunovion Respiratory Development Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2018-01-25